ESC 365 - Assessment of the microvascular resistance reserve for predicting the effect of revascularization in patients with moderate coronary stenoses.

ESC Professional Premium Access

Assessment of the microvascular resistance reserve for predicting the effect of revascularization in patients with moderate coronary stenoses.

Session: Smaller trials, trial updates, and other studies on coronary artery disease and coronary revascularisation

Topic: Intracoronary Flow and Pressure Measurements

Speaker: Doctor L. Rasmussen (Herning, DK)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Laust Dupont Rasmussen

Regional Hospital Godstrup, Herning (Denmark)

1 presentation

2 followers

3 more presentations in this session

Long-term effect of biodegradable versus durable polymer drug-eluting stents on neoatherosclerosis among STEMI patients: the international CONNECT randomized controlled intracoronary OCT trial

Speaker: Doctor J. Haener (Bern, CH)

Glycoprotein IIb/IIIa Inhibitors in patients with acute myocardial infarction and angiographic no-reflow: the randomized REVERSE-FLOW trial

Speaker: Professor I. Eitel (Luebeck, DE)

Evaluation of ambulatory electrocardiographic monitoring of patients after high-risk acute coronary syndrome. A randomized trial.

Speaker: Doctor J. De La Torre Hernandez (Santander, ES)

Access the full session

Smaller trials, trial updates, and other studies on coronary artery disease and coronary revascularisation

Speakers: Doctor L. Rasmussen, Doctor J. Haener, Professor I. Eitel, Doctor J. De La Torre Hernandez

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources